Photodynamic therapy-mediated cancer vaccination enhances stem-like phenotype and immune escape, which can be blocked by thrombospondin-1 signaling through CD47 receptor protein

Journal of Biological Chemistry

Volumn 290, Issue 14, 2015, Pages 8975-8986

  Zheng, Yuanhong ^a   Zou, Fangyuan ^a   Wang, Jingjing ^a   Yin, Guifang ^a   Le, Vanminh ^a   Fei, Zhewei ^b   Liu, Jianwen ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DISEASES; PHOTODYNAMIC THERAPY; TUMORS; VACCINES;

CANCER IMMUNOTHERAPY; CLINICAL OUTCOME; IMMUNOGENICITY; MICROENVIRONMENTS; POSITIVE SOLUTION; RECEPTOR PROTEINS; THERAPEUTIC BENEFITS; THROMBOSPONDIN;

CELL SIGNALING;

CD47 RECEPTOR PROTEIN; GLYCOPROTEIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; CANCER VACCINE; CD47 ANTIGEN; CD47 PROTEIN, MOUSE; THROMBOSPONDIN-1, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PHENOTYPE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STEM LIKE PHENOTYPE; TREATMENT FAILURE; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER STEM CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; PHOTOCHEMOTHERAPY;

ANIMALS; ANTIGENS, CD47; CANCER VACCINES; IMMUNOPHENOTYPING; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; PHOTOCHEMOTHERAPY; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1; TUMOR ESCAPE;

EID: 84926512813     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.624965     Document Type: Article

References (52)

1. Sharma, P., Wagner, K., Wolchok, J. D., and Allison, J. P. (2011) Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat. Rev. Cancer 11, 805-812
2. Liu, T., Wu, L. Y., Choi, J. K., and Berkman, C. E. (2010) Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway. Int. J. Oncol. 36, 777-784
3. Galluzzi, L., Kepp, O., and Kroemer, G. (2012) Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J. 31, 1055-1057
4. Garg, A. D., Nowis, D., Golab, J., and Agostinis, P. (2010) Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis 15, 1050-1071
5. Garg, A. D., Krysko, D. V., Vandenabeele, P., and Agostinis, P. (2012) Hypericin-based photodynamic therapy induces surface exposure of dam-age-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol. Immunother. 61, 215-221
6. Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J., Annaert, W., Golab, J., de Witte, P., Vandenabeele, P., and Agostinis, P. (2012) A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 31, 1062-1079
7. Jung, N. C., Kim, H. J., Kang, M. S., Lee, J. H., Song, J. Y., Seo, H. G., Bae, Y. S., and Lim, D. S. (2012) Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors. Cancer Lett. 324, 58-65
8. Palucka, K., and Banchereau, J. (2012) Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12, 265-277
9. Schatton, T., and Frank, M. H. (2009) Antitumor immunity and cancer stem cells. Ann. N.Y. Acad. Sci. 1176, 154-169
10. Aptsiauri, N., Carretero, R., Garcia-Lora, A., Real, L. M., Cabrera, T., and Garrido, F. (2008) Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations. Cancer Immunol. Immunother. 57, 1727-1733
11. Wilczyński, J. R., and Duechler, M. (2010) How do tumors actively escape from host immunosurveillance? Arch. Immunol. Ther. Exp. (Warsz) 58, 435-448
12. Noh, K. H., Lee, Y. H., Jeon, J. H., Kang, T. H., Mao, C. P., Wu, T. C., and Kim, T. W. (2012) Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype. Cancer Res. 72, 1717-1727
13. Schreiber, R. D., Old, L. J., and Smyth, M. J. (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570
14. Brown, E. J., and Frazier, W. A. (2001) Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11, 130-135
15. Sarfati, M., Fortin, G., Raymond, M., and Susin, S. (2008) CD47 in the immune response: role of thrombospondin and SIRP-α reverse signaling. Curr. Drug Targets 9, 842-850
16. Willingham, S. B., Volkmer, J. P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., Lovelace, P., Scheeren, F. A., Chao, M. P., Weiskopf, K., Tang, C., Volkmer, A. K., Naik, T. J., Storm, T. A., Mosley, A. R., Edris, B., Schmid, S. M., Sun, C. K., Chua, M. S., Murillo, O., Rajendran, P., Cha, A. C., Chin, R. K., Kim, D., Adorno, M., Raveh, T., Tseng, D., Jaiswal, S., Enger, P. Ø., Steinberg, G. K., Li, G., So, S. K., Majeti, R., Harsh, G. R., van de Rijn, M., Teng, N. N., Sunwoo, J. B., Alizadeh, A. A., Clarke, M. F., and Weissman, I. L. (2012) The CD47-signal regulatory protein α (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. U.S.A. 109, 6662-6667
17. Burger, P., Hilarius-Stokman, P., de Korte, D., van den Berg, T. K., and van Bruggen, R. (2012) CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 119, 5512-5521
18. Zhao, X. W., van Beek, E. M., Schornagel, K., Van der Maaden, H., Van Houdt, M., Otten, M. A., Finetti, P., Van Egmond, M., Matozaki, T., Kraal, G., Birnbaum, D., van Elsas, A., Kuijpers, T. W., Bertucci, F., and van den Berg, T. K. (2011) CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction. Proc. Natl. Acad. Sci. U.S.A. 108, 18342-18347
19. Chao, M. P., Weissman, I. L., and Majeti, R. (2012) The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr. Opin. Immunol. 24, 225-232
20. Miller, T. W., Kaur, S., Ivins-O'Keefe, K., and Roberts, D. D. (2013) Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation. Matrix Biol. 32, 316-324
21. Grimbert, P., Bouguermouh, S., Baba, N., Nakajima, T., Allakhverdi, Z., Braun, D., Saito, H., Rubio, M., Delespesse, G., and Sarfati, M. (2006) Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation. J. Immunol. 177, 3534-3541
22. Kaur, S., Martin-Manso, G., Pendrak, M. L., Garfield, S. H., Isenberg, J. S., and Roberts, D. D. (2010) Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J. Biol. Chem. 285, 38923-38932
23. Dasgupta, P., Rizwani, W., Pillai, S., Davis, R., Banerjee, S., Hug, K., Lloyd, M., Coppola, D., Haura, E., and Chellappan, S. P. (2011) ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors. J. Natl. Cancer Inst. 103, 317-333
24. Vermeer, D. W., Spanos, W. C., Vermeer, P. D., Bruns, A. M., Lee, K. M., and Lee, J. H. (2013) Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer. Int. J. Cancer 133, 120-129
25. Ma, L., Mao, R., Shen, K., Zheng, Y., Li, Y., Liu, J., and Ni, L. (2014) Atractylenolide I-mediated Notch pathway inhibition attenuates gastric cancer stem cell traits. Biochem. Biophys. Res. Commun. 450, 353-359
26. Zheng, Y., Le, V., Cheng, Z., Xie, S., Li, H., Tian, J., and Liu, J. (2013) Development of rapid and highly sensitive HSPA1A promoter-driven luciferase reporter system for assessing oxidative stress associated with low-dose photodynamic therapy. Cell Stress Chaperones 18, 203-213
27. Ramakrishnan, R., Assudani, D., Nagaraj, S., Hunter, T., Cho, H. I., Antonia, S., Altiok, S., Celis, E., and Gabrilovich, D. I. (2010) Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. J. Clin. Invest. 120, 1111-1124
28. Shirota, Y., Shirota, H., and Klinman, D. M. (2012) Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J. Immunol. 188, 1592-1599
29. Di Stefano, B., Prigione, A., and Broccoli, V. (2009) Efficient genetic reprogramming of unmodified somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4. Stem Cells Dev. 18, 707-716
30. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25, 402-408
31. Shen, K., Liang, Q., Xu, K., Cui, D., Jiang, L., Yin, P., Lu, Y., Li, Q., and Liu, J. (2012) MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem. Pharmacol. 84, 320-330
32. Morrison, B. J., Steel, J. C., and Morris, J. C. (2012) Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells. PloS ONE 7, e49752
33. Fucikova, J., Kralikova, P., Fialova, A., Brtnicky, T., Rob, L., Bartunkova, J., and Spísek, R. (2011) Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res. 71, 4821-4833
34. Mroz, P., Szokalska, A., Wu, M. X., and Hamblin, M. R. (2010) Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PloS ONE 5, e15194
35. Rivera, C., Rivera, S., Loriot, Y., Vozenin, M. C., and Deutsch, E. (2011) Lung cancer stem cell: new insights on experimental models and preclinical data. J. Oncol. 2011, 549181
36. Huang, C. P., Tsai, M. F., Chang, T. H., Tang, W. C., Chen, S. Y., Lai, H. H., Lin, T. Y., Yang, J. C., Yang, P. C., Shih, J. Y., and Lin, S. B. (2013) ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett. 328, 144-151
37. Zhang, A. M., Fan, Y., Yao, Q., Ma, H., Lin, S., Zhu, C. H., Wang, X. X., Liu, J., Zhu, B., Sun, J. G., and Chen, Z. T. (2012) Identification of a cancer stem-like population in the Lewis lung cancer cell line. Asian Pac. J. Cancer Prev. 13, 761-766
38. Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., and De Maria, R. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504-514
39. Tirino, V., Camerlingo, R., Franco, R., Malanga, D., La Rocca, A., Viglietto, G., Rocco, G., and Pirozzi, G. (2009) The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur. J. Cardiothorac. Surg. 36, 446-453
40. Korbelik, M., and Merchant, S. (2012) Photodynamic therapy-generated cancer vaccine elicits acute phase and hormonal response in treated mice. Cancer Immunol. Immunother. 61, 1387-1394
41. Kabingu, E., Vaughan, L., Owczarczak, B., Ramsey, K. D., and Gollnick, S. O. (2007) CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br. J. Cancer 96, 1839-1848
42. Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., Korbelik, M., Moan, J., Mroz, P., Nowis, D., Piette, J., Wilson, B. C., and Golab, J. (2011) Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61, 250-281
43. Kaur, S., Soto-Pantoja, D. R., Stein, E. V., Liu, C., Elkahloun, A. G., Pendrak, M. L., Nicolae, A., Singh, S. P., Nie, Z., Levens, D., Isenberg, J. S., and Roberts, D. D. (2013) Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci. Rep. 3, 1673
44. Lawler, J. (2002) Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J. Cell. Mol. Med. 6, 1-12
45. Bornstein, P. (2009) Thrombospondins function as regulators of angiogenesis. J. Cell Commun. Signal. 3, 189-200
46. Taraboletti, G., Rusnati, M., Ragona, L., and Colombo, G. (2010) Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors. Oncotarget 1, 662-673
47. Baek, K. H., Bhang, D., Zaslavsky, A., Wang, L. C., Vachani, A., Kim, C. F., Albelda, S. M., Evan, G. I., and Ryeom, S. (2013) Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. J. Clin. Invest. 123, 4375-4389
48. Isenberg, J. S., Annis, D. S., Pendrak, M. L., Ptaszynska, M., Frazier, W. A., Mosher, D. F., and Roberts, D. D. (2009) Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses. J. Biol. Chem. 284, 1116-1125
49. Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W., and Phang, J. M. (2012) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc. Natl. Acad. Sci. U.S.A. 109, 8983-8988
50. Chiou, S. H., Wang, M. L., Chou, Y. T., Chen, C. J., Hong, C. F., Hsieh, W. J., Chang, H. T., Chen, Y. S., Lin, T. W., Hsu, H. S., and Wu, C. W. (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 70, 10433-10444
51. Herreros-Villanueva, M., Zhang, J. S., Koenig, A., Abel, E. V., Smyrk, T. C., Bamlet, W. R., de Narvajas, A. A., Gomez, T. S., Simeone, D. M., Bujanda, L., and Billadeau, D. D. (2013) SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2, e61
52. Wang, W. J., Wu, S. P., Liu, J. B., Shi, Y. S., Huang, X., Zhang, Q. B., and Yao, K. T. (2013) MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells. Cancer Res. 73, 1219-1231.